London · Delayed Price · Currency is GBP · Price in GBX Aptamer Group Company Description
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.
The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules.
Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications.
The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius.
Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.
| Country | United Kingdom |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Arron Tolley |
Contact Details
Address: Windmill House York, YO10 5BR United Kingdom | |
| Phone | 44 19 0421 7404 |
| Website | aptamergroup.com |
Stock Details
| Ticker Symbol | APTA |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | July - June |
| Reporting Currency | GBP |
| ISIN Number | GB00BNRRP542 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Arron Tolley | Chief Executive Officer |
| Andrew Rapson | Chief Financial Officer |